forecast glp-1 prescriptions growth 2025 semaglutide tirzepatide Drugs Market Size to Hit USD 132.79 Bn by 2035 GLP-1 Agonists Weight Loss Drugs
Description
GLP-1 medications and hormone therapies have moved from niche to mainstream
Semaglutide/Tirzepatide emerges as a beacon of hope for individuals grappling with the challenges of type 2 diabetes and obesity.
The company attributes the turnaround to changed GLP-1 policies, a milder flu season and workforce buyouts that affected roughly 18% of employees.
Third-party tested.
